The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...

Even before the F.D.A. approval, some doctors have been prescribing weight loss drugs to people with sleep apnea. The F.D.A.’s decision may place added pressure on insurance companies to cover ...

Over her three-decade career, weight management physician Dr. Sarah Ro has seen hundreds of patients. Many of them are on ...

For about 25 million Americans who suffer from obstructive sleep apnea, there are various effective treatments such as CPAP breathing machines, surgery, a dental mouthpiece and even an implantable pac ...

The Food and Drug Administration approved Zepbound as the first prescription medicine to treat sleep apnea on Friday ... which had Zepbound approved as a weight-loss drug last year.

Zepbound is the first medication approved to treat patients with obstructive sleep apnea ... 1 drugs Ozempic and Wegovy, this class of medications has become wildly popular as weight-loss and ...

The expanded approval could persuade more insurance companies — which have been reluctant to cover the expensive weight loss ...

The federal agency authorized the use of the Eli Lilly & Co. weight loss drug for “treatment of moderate to severe ...

Obstructive sleep apnea occurs when a person’s upper ... Medicare does not cover weight-loss drugs specifically for obesity, although the medications can be covered for conditions exacerbated ...

“This is a major step forward for patients with obstructive sleep apnea,” Dr. Sally Seymour ... which doesn’t cover drugs solely for weight loss. Without insurance coverage, Zepbound ...

The weight loss drug Zepbound has become the first prescription medication approved to treat obstructive sleep apnea. The ...

Advertising Even before the FDA approval, some doctors have been prescribing weight-loss drugs to people with sleep apnea. The FDA’s decision may place added pressure on insurance companies to ...